Northeast Iowa Behavioral Health, Inc. - Medicare Mental Health Clinic in Decorah, IA

Northeast Iowa Behavioral Health, Inc. is a medicare enrolled mental health clinic (Clinic/center - Mental Health (including Community Mental Health Center)) in Decorah, Iowa. The current practice location for Northeast Iowa Behavioral Health, Inc. is 905 Montgomery St, Decorah, Iowa. For appointments, you can reach them via phone at (563) 382-3649. The mailing address for Northeast Iowa Behavioral Health, Inc. is Po Box 349, 905 Montgomery St., Decorah, Iowa and phone number is (563) 382-3649.

Northeast Iowa Behavioral Health, Inc. is licensed to practice in Iowa (license number NONE). The clinic also participates in the medicare program and its NPI number is 1710933445. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (563) 382-3649.

Contact Information

Northeast Iowa Behavioral Health, Inc.
905 Montgomery St
Decorah
IA 52101-2325
(563) 382-3649
(563) 382-8183

Mental Health Clinic Profile

Full NameNortheast Iowa Behavioral Health, Inc.
SpecialityClinic/Center
Location905 Montgomery St, Decorah, Iowa
Authorized Official Name and PositionMarcia Oltrogge (EXECUTIVE DIRECTOR)
Authorized Official Contact5633823649
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Northeast Iowa Behavioral Health, Inc.
Po Box 349
905 Montgomery St.
Decorah
IA 52101-0349

Ph: (563) 382-3649
Northeast Iowa Behavioral Health, Inc.
905 Montgomery St
Decorah
IA 52101-2325

Ph: (563) 382-3649

NPI Details:

NPI Number1710933445
Provider Enumeration Date05/25/2006
Last Update Date04/18/2012

Medicare PECOS Information:

Medicare PECOS PAC ID1355230475
Medicare Enrollment IDO20040315000839

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

Medical Identifiers

Medical identifiers for Northeast Iowa Behavioral Health, Inc. such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1710933445NPI-NPPES
0074559MedicaidIA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
261QM0801XClinic/center - Mental Health (including Community Mental Health Center) NONE (Iowa)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Northeast Iowa Behavioral Health, Inc. acts as a billing entity for following providers:
Provider NameWilliam Bernard Deutsch
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1609179787
PECOS PAC ID: 8426210758
Enrollment ID: I20120503000324

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

Provider NameChristel J Rinehart
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1952689523
PECOS PAC ID: 6507037504
Enrollment ID: I20130122000568

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

Provider NameKovilparambil Antony
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1376677138
PECOS PAC ID: 7113910266
Enrollment ID: I20140630001733

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

Provider NameChitchawal Sahatevasukont
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1053661074
PECOS PAC ID: 9436395944
Enrollment ID: I20140725001915

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

Provider NameLaura J Zielinski
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1801148366
PECOS PAC ID: 8729212477
Enrollment ID: I20210628000965

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

Provider NameKathryn Quinn Johnson
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1356787873
PECOS PAC ID: 7012142953
Enrollment ID: I20210907000129

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

Provider NameErin Anderson
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1164980462
PECOS PAC ID: 0345634101
Enrollment ID: I20220222001396

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

Provider NameMargaret A Throckmorton
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1902372790
PECOS PAC ID: 3072859511
Enrollment ID: I20220707003928

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

Provider NameElizabeth Anne Mcerlean
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1942760137
PECOS PAC ID: 0042636557
Enrollment ID: I20230201000466

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

Provider NameMegan Andera
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1083225130
PECOS PAC ID: 1759746258
Enrollment ID: I20230506000224

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

Provider NameMatthew Homstad
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1134574064
PECOS PAC ID: 1658729710
Enrollment ID: I20231129003280

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

Provider NameNicole Brevig
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1659938165
PECOS PAC ID: 8022466069
Enrollment ID: I20231130003031

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

Provider NameKendrah Parker
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1427456581
PECOS PAC ID: 1254780562
Enrollment ID: I20231212003352

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

Provider NameAdam Elwood
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1376109132
PECOS PAC ID: 2769832633
Enrollment ID: I20231219002694

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more Medical News

› Verified 4 days ago

News Archive

Novel antidepressant targets brain receptors responsible for learning and memory

A first-of-its-kind antidepressant drug discovered by a Northwestern University professor and now tested on adults who have failed other antidepressant therapies has been shown to alleviate symptoms within hours, have good safety and produce positive effects that last for about seven days from a single dose.

Praesidian Capital invests $6 million in Meta Pharmaceutical Services

Praesidian Capital, a leading provider of mezzanine capital for small and mid-sized companies, has invested $6 million in subordinated debt in Meta Pharmaceutical Services, a leading sales and marketing data services provider. The investment supports the recapitalization of Meta Pharmaceutical Services by DFW Capital Partners and management.

Mapping rhomboid enzymes could eventually lead to drugs to treat malaria

Johns Hopkins scientists have decoded for the first time the "stability blueprint" of an enzyme that resides in a cell's membrane, mapping which parts of the enzyme are important for its shape and function.

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

Read more News

› Verified 4 days ago

Clinic/Center in Decorah, IA

Therapy Associates
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 314 W Main St, Decorah, IA 52101
Phone: 563-382-2662    Fax: 563-382-2662
Margaret M Hammes
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 314 W Main St, Decorah, IA 52101
Phone: 563-387-7433    
Heron Consulting, Inc.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 603 Sunrise Blvd, Decorah, IA 52101
Phone: 563-419-1124    Fax: 563-387-2303
Restorative Therapy & Psychiatric Care, Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1111 Paine St, Decorah, IA 52101
Phone: 563-379-8969    
Choice Employment Services
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 709 Decorah Ave, Decorah, IA 52101
Phone: 563-419-8278    
Lighthouse Professional Counseling Services, Llc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1111 Paine St, Suite D, Decorah, IA 52101
Phone: 563-382-1900    Fax: 563-382-1777

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.